Cellular and Humoral Cross-Immunity against Two H3N2v Influenza Strains in Presumably Unexposed Healthy and HIV-Infected Subjects

被引:5
作者
Agrati, Chiara [1 ,2 ]
Castilletti, Concetta [1 ]
Cimini, Eleonora [2 ]
Lapa, Daniele [1 ]
Quartu, Serena [1 ]
Caglioti, Claudia [1 ]
Lanini, Simone [3 ]
Cattoli, Giovanni [4 ]
Martini, Federico [2 ]
Ippolito, Giuseppe [3 ]
Capobianchi, Maria R. [1 ]
机构
[1] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Virol Lab, Rome, Italy
[2] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Cellular Immunol Lab, Rome, Italy
[3] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Dept Epidemiol, Rome, Italy
[4] Ist Zooprofilatt Sperimentale Venezie, Padua, Italy
关键词
A VIRUS; EMERGING VARIANTS; UNITED-STATES; T-CELLS; PROTECTION; VACCINE; H1N1; IMMUNOGENICITY; TRANSMISSION; MORTALITY;
D O I
10.1371/journal.pone.0105651
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Human cases of infection due to a novel swine-origin variant of influenza A virus subtype H3N2 (H3N2v) have recently been identified in the United States. Pre-existing humoral and cellular immunity has been recognized as one of the key factors in limiting the infection burden of an emerging influenza virus strain, contributing to restrict its circulation and to mitigate clinical presentation. Aim of this study was to assess humoral and cell-mediated cross immune responses to H3N2v in immuno-competent (healthy donors, n = 45) and immuno-compromised hosts (HIV-infected subjects, n = 46) never exposed to H3N2v influenza strain. Humoral response against i) H3N2v (A/H3N2/Ind/08/11), ii) animal vaccine H3N2 strain (A/H3N2/ Min/11/10), and iii) pandemic H1N1 virus (A/H1N1/Cal/07/09) was analysed by hemagglutination inhibition assay; cell-mediated response against the same influenza strains was analysed by ELISpot assay. A large proportion of healthy and HIV subjects displayed cross-reacting humoral and cellular immune responses against two H3N2v strains, suggesting the presence of B-and T-cell clones able to recognize epitopes from emerging viral strains in both groups. Specifically, humoral response was lower in HIV subjects than in HD, and a specific age-related pattern of antibody response against different influenza strains was observed both in HD and in HIV. Cellular immune response was similar between HD and HIV groups and no relationship with age was reported. Finally, no correlation between humoral and cellular immune response was observed. Overall, a high prevalence of HD and HIV patients showing cross reactive immunity against two H3N2v strains was observed, with a slightly lower proportion in HIV persons. Other studies focused on HIV subjects at different stages of diseases are needed in order to define how cross immunity can be affected by advanced immunosuppression.
引用
收藏
页数:9
相关论文
共 40 条
[1]  
Agrati C, 2012, AIDS RES HUM RETROV, V28, P1606, DOI [10.1089/aid.2011.0371, 10.1089/AID.2011.0371]
[2]   Association of Profoundly Impaired Immune Competence in H1N1v-Infected Patients with a Severe or Fatal Clinical Course [J].
Agrati, Chiara ;
Gioia, Cristiana ;
Lalle, Eleonora ;
Cimini, Eleonora ;
Castilletti, Concetta ;
Armignacco, Orlando ;
Lauria, Francesco Nicola ;
Ferraro, Federica ;
Antonini, Mario ;
Ippolito, Giuseppe ;
Capobianchi, Maria Rosaria ;
Martini, Federico .
JOURNAL OF INFECTIOUS DISEASES, 2010, 202 (05) :681-689
[3]   Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: Basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season [J].
Barr, Ian G. ;
McCauley, John ;
Cox, Nancy ;
Daniels, Rod ;
Engelhardt, Othmar G. ;
Fukuda, Keiji ;
Grohmann, Gary ;
Hay, Alan ;
Kelso, Anne ;
Klimov, Alexander ;
Odagiri, Takato ;
Smith, Derek ;
Russell, Colin ;
Tashiro, Masato ;
Webby, Richard ;
Wood, John ;
Ye, Zhiping ;
Zhang, Wenqing .
VACCINE, 2010, 28 (05) :1156-1167
[4]   TRANSGENIC MICE LACKING CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED T-CELLS HAVE DELAYED VIRAL CLEARANCE AND INCREASED MORTALITY AFTER INFLUENZA-VIRUS CHALLENGE [J].
BENDER, BS ;
CROGHAN, T ;
ZHANG, LP ;
SMALL, PA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (04) :1143-1145
[5]   Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1 [J].
Berthoud, Tamara K. ;
Hamill, Matthew ;
Lillie, Patrick J. ;
Hwenda, Lenias ;
Collins, Katharine A. ;
Ewer, Katie J. ;
Milicic, Anita ;
Poyntz, Hazel C. ;
Lambe, Teresa ;
Fletcher, Helen A. ;
Hill, Adrian V. S. ;
Gilbert, Sarah C. .
CLINICAL INFECTIOUS DISEASES, 2011, 52 (01) :1-7
[6]  
Branch Alicia, 2012, Morbidity and Mortality Weekly Report, V61, P237
[7]  
Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P561
[8]  
Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V60, P1741
[9]   Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8+ T-cell memory [J].
Christensen, JP ;
Doherty, PC ;
Branum, KC ;
Riberdy, JM .
JOURNAL OF VIROLOGY, 2000, 74 (24) :11690-11696
[10]  
Cox CM, 2011, EMERG INFECT DIS, V17, P1143, DOI [10.3201/eid1706.101488, 10.3201/eid/1706.101488]